一个具有肝细胞平衡的二维C型肝炎病毒模型的混乱和分叉
1Department of Mathematics, University of Azad Jammu and Kashmir, Muzaffarabad 13100, Pakistan.
Chaos (Woodbury, N.Y.)
|June 5, 2024
概括
这项研究分析了型肝炎病毒 (HCV) 动态和肝细胞平衡,使用分叉分析和混乱控制策略来稳定系统. 数字模拟验证了管理不稳定的HCV模型行为的方法.
科学领域:
- 数学生物学 数学生物学
- 病毒学 病毒学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 型肝炎病毒 (HCV) 感染影响肝脏健康,需要模型来理解其复杂的动态.
- 肝细胞平衡对于肝功能至关重要,并且可能因病毒感染而受到干扰.
- 了解平衡点的局部动态是预测疾病进展的关键.
研究的目的:
- 为了研究肝细胞恒温的二维HCV模型的分支集和动态.
- 分析参数变化如何诱导分叉并改变系统行为.
- 在HCV模型中应用混合控制反和奥特-格雷博吉-约克的混沌缓解策略.
主要方法:
- 分叉分析以确定关键参数值.
- 实施混合控制反策略.
- 应用奥特-格雷博吉-约克 (OGY) 混沌控制.
- 广泛的数值模拟用于验证.
主要成果:
- 确定了双叉集和在平衡点分析了系统动态.
- 证明了翻转和尼马克-萨克分叉有助于系统混乱.
- 成功应用控制策略来稳定混乱的HCV模型.
- 数字模拟证实了关于混乱控制有效性的理论发现.
结论:
- 该研究提供了对HCV模型动态的全面理解,包括混乱的行为.
- 混合控制和OGY战略在管理和稳定复杂的HCV动态方面是有效的.
- 这些发现提供了对通过控制病毒系统混乱来治疗HCV的潜在治疗干预措施的见解.
相关概念视频
Hepatic Portal System
8.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
8.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
502
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
502
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
398
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
398
Hepatitis
86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction
25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42


